Ubs Group Ag Cardlytics, Inc. Transaction History
Ubs Group Ag
- $527 Billion
- Q4 2024
A detailed history of Ubs Group Ag transactions in Cardlytics, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 188,769 shares of CDLX stock, worth $458,708. This represents 0.0% of its overall portfolio holdings.
Number of Shares
188,769
Previous 47,147
300.38%
Holding current value
$458,708
Previous $150,000
366.67%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding CDLX
# of Institutions
122Shares Held
30.4MCall Options Held
509KPut Options Held
263K-
Cliff Sosin Cas Investment Partners, LLC | New York, Ny6.37MShares$15.5 Million1.38% of portfolio
-
Black Rock Inc. New York, NY3.15MShares$7.66 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$6.54 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY1.31MShares$3.18 Million0.35% of portfolio
-
Kps Global Asset Management Uk LTD London, X01.22MShares$2.96 Million0.92% of portfolio
About Cardlytics, Inc.
- Ticker CDLX
- Exchange NASDAQ
- Sector Communication Services
- Industry Advertising Agencies
- Shares Outstandng 32,893,800
- Market Cap $79.9M
- Description
- Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and var...